Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy

Elisabetta Giannotti1, Jonathan James1, Yan Chen2, Rachel Sun1, Amanjot Karuppiah1, Julia Yemm3, Andrew H.S. Lee4
1Nottingham Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
2Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK
3Department of Radiology, King’s Mill Hospital, Mansfield, UK
4Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Non-operative Diagnosis Subgroup of the National Coordinating Committee for Breast Screening Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. [Internet]. The Royal College of Pathologists 2016. Available from: https://www.rcpath.org/uploads/assets/4b16f19c-f7bd-456c-b212f557f8040f66/G150-Non-op-reporting-breast-cancer-screening-Feb17.pdf

Pinder SE, Shaaban A, Deb R et al (2018) NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol 73(8):682–692. https://doi.org/10.1016/j.crad.2018.04.004

Bianchi S, Caini S, Renne G et al (2011) Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy. Breast 20:264–270. https://doi.org/10.1016/j.breast.2010.12.003

Eusebi V, Feudale E, Foschini MP et al (1994) Long term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11(3):223–235

Moseholm E, Rydahl-Hansen S, Overgaard D et al (2016) Health-related quality of life, anxiety and depression in the diagnostic phase of suspected cancer, and the influence of diagnosis. Health Qual Life Outcomes 14(1):1. https://doi.org/10.1186/s12955-016-0484-9

Brennan ME, Turner RM, Ciatto S et al (2011) Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260:119–228. https://doi.org/10.1148/radiol.11102368

Bennett IC (2017) The changing role of vacuum-assisted biopsy of the breast: a new prototype of minimally invasive breast surgery. Clin Breast Cancer 17(5):323–325. https://doi.org/10.1016/j.clbc.2017.03.001

Tennant SL, Evans A, Hamilton LJ et al (2008) Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) – an alternative to surgery in selected cases. Breast 17:546–549. https://doi.org/10.1016/j.breast.2008.08.005

Brenner RJ, Jackman RJ, Parker SH et al (2002) Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary? AJR Am J Roentgenol 179:1179–1184. https://doi.org/10.2214/ajr.179.5.1791179

O’Flynn EA, Wilson AR, Michell MJ (2010) Image-guided breast biopsy: state-of-the-art. Clin Radiol 65(4):259–270. https://doi.org/10.1016/j.crad.2010.01.008

Rageth CJ, O’Flynn EAM, Pinker K et al (2019) Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 174(2):279–296. https://doi.org/10.1007/s10549-018-05071-1

Rageth CJ, O’Flynn EA, Comstock C et al (2016) First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 159(2):203–213. https://doi.org/10.1007/s10549-016-3935-4

Strachan C, Horgan K, Millican-Slater RA, Shaaban AM, Sharma N (2016) Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice? J Clin Pathol 69(3):248–254. https://doi.org/10.1136/jclinpath-2015-203018

NHS Breast Screening Programme. Clinical guidance for breast cancer screening assessment. NHSBSP publication no. 49. 4th edn 2016. [Internet]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/465694/nhsbsp20.pdf.

Guidelines for performing breast and axillary biopsies in patient on anticoagulant and antiplatelet therapy [Internet]. British Society of Breast Radiology 2018. Available from: https://breastradiology.org/media/1022/bsbr-anticoag-guidelines-august-2018.pdf

Houssami N, Ciatto S, Ellis I, Ambrogetti D (2007) Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 109:487–495. https://doi.org/10.1002/cncr.22435

Abdulcadir D, Nori J, Meattini I et al (2014) Phylloides tumours of the breast diagnosed as B3 category on image-guided 14-guage core biopsy: analysis of 51 cases from a single institution and review of the literature. Eur J Surg Oncol 40:859–864. https://doi.org/10.1016/j.ejso.2014.02.222

El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO (2008) Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur J Cancer 44:2580–2586. https://doi.org/10.1016/j.ejca.2008.05.024

Rakha EA, Ho BC, Naik et al (2011) Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia. Histopathology 58:626–632. https://doi.org/10.1111/j.1365-2559.2011.03786.x

Sohn V, Arthurs Z, Herbert G et al (2007) Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle. Ann Surg Oncol 14:2497–2501. https://doi.org/10.1245/s10434-007-9454-0

Rakha EA, Lee AHS, Jenkins JA, Murphy AE, Hamilton LJ, Ellis IO (2011) Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) abnormalities detected by mammographic screening. Int J Cancer 129:1417–1424. https://doi.org/10.1002/ijc.25801

Mayer S, Kayser G, Rucker G et al (2017) Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk of malignancy. Breast 31:144–149. https://doi.org/10.1016/j.breast.2016.11.007

Fine RE, Boyd BA, Whitworth PW, Kim JA, Harness JK, Burak WE (2002) Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance. Am J Surg 184:332–336. https://doi.org/10.1016/s0002-9610(02)00951-0

Mathew J, Crawford DJ, Lwin M, Barwick C, Gash A (2007) Ultrasound-guided, vacuum assisted excision in the diagnosis and treatment of clinically benign breast lesions. Ann R Coll Surg Engl 89:494–496. https://doi.org/10.1308/003588407X187621

Alonso-Bartolomé P, Vega-Bolivar A, Torres-Tabanera M et al (2004) Sonographically guided 11G directional vacuum-assisted breast biopsy as an alternative to surgical excision: ultility and cost study in probably benign lesions. Acta Radiol 45:390–396. https://doi.org/10.1080/02841850410005633

Sharma N, Wilkinson LS, Pinder SE (2016) The B3 conundrum – the radiologists’ perspective. Br J Radiol 90:20160595. https://doi.org/10.1259/bjr.20160595

Batohi B, Fang C, Michell MJ et al (2019) An audit of mammographic screen detected lesions of uncertain malignant potential (b3) diagnosed on initial image guided needle biopsy: how has our practice changed over 10 years. Clin Radiol 653:e19–653.e25. https://doi.org/10.1016/j.crad.2019.04.006